The Value of Basic Science in Healthcare by Prof. Michael F. Flessner

The Value of Basic Science in Healthcare by Prof. Michael F. Flessner
2.5 5

Published November 1st, 2010 - 11:56 GMT

Rate Article:

 
PRINT Send Mail
comment (0)
More >
Hamad Medical Corporation
,
Basic Science Track
,
Al Hareth M. Al Khater
,
Mississippi Medical Center
,
National Institute of Health
,
Peritoneal Dialysis Unit
,
Substantial Service
,
Medical Research Center
,
University of Rochester
,
National Institute of Diabetes and Digestive
,
University of Mississippi
,
Digestive and Kidne

Basic science in the field of healthcare refers to any science that relates to the prevention, cure or alleviation of disease. At Qatar Health 2010 for the first time a Basic Science track is offered and the major themes this year include Resuscitation Science and Peritoneal Chemotherapeutic Drug Delivery in Pelvic-abdominal Cancers. Both are clinical problems that still require extensive research to provide many answers.

"While the implications for discoveries in basic research are sometimes unknown, discoveries by basic science researchers become the foundation for important breakthroughs in medical treatments and diagnostic technologies," said Dr Al Hareth M. Al Khater, Chairman of the Medical Research Center (MRC) which is the overall governing research body at Hamad Medical Corporation's (HMC); he is also the Chairman of the Basic Science track. "The Basic Science Track will provide up-to-date information and findings about the basic biomedical research effort from clinical perspectives".

Professor Michael F. Flessner was the John Bower Professor of Nephrology and Hypertension and Professor of Physiology and Biophysics, University of Mississippi Medical Center, is one of the internationally renowned speakers participating in this track.

Prof. Flessner was Director of the Peritoneal Dialysis Unit at the University of Rochester where he carried out basic and clinical research on peritoneal transport and inflammation. In addition to this, he published extensively in cancer research. Dr. Flessner was listed among the National Institutes of Health (NIH) Reviewers with Substantial Service (Six times in 18 months ending April 30, 2009), and currently serving in the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).

"I heard about Qatar Health 2010 from a colleague and did some research to find that it has a great program. It represents an opportunity to exchange expertise between healthcare professionals, and to learn about advances in the medical research and technology. I'm delighted to participate in the Basic Science Track," Dr. Flessner said.

Prof. Flessner is a researcher, a training program director, and a strong advocate of increased support for young investigators in basic and clinical research. He will cover two main topics in his lecture: The peritoneal route for chemotherapeutic drug delivery and what limits penetration of chemotherapeutic agents in pelvic-abdominal cancer. 

Advertisement

Post new comment

The content of this field is kept private and will not be shown publicly.